ArticleCell death & disease2024
Enzalutamide inhibits PEX10 function and sensitizes prostate cancer cells to ROS activators.
Yuankang Feng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleCell death & disease2024
Yuankang Feng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.